1. Amato RJ (2003) Thalidomide therapy for renal cell carcinoma. Crit Rev Oncol Hematol 46: 59–65
2. Amato RJ (2005) Renal cell carcinoma: a review of novel single-agent therapeutics and combination regimens Ann Oncol 16: 7–15
3. Amato RJ, Schell J, Thompson N et al. (2003) Phase II study of thalido-mide + interleukin-2 in patients with metastatic renal cell carci-noma. Proc Am Soc Clin Oncol 22: Abstract 1556
4. Assikis VJ, Daliani D, Magliaro L et al. (2003) Phase II study of an autolo-gous tumor derived heat shock protein-peptide complex vaccine (HSSPC-96) for patients with metastatic renal cell carcinoma. Proc Am Soc Clin Oncol 22: Abstract 1552)
5. Atkins MB, Hidalgo M, Stadler W et al. (2002) A randomized double-blind phase 2 study of intravenous CCI-779 administered weekly to patients with advanced renal cell carcinoma. Proc Am Soc Clin Onco 21: Abstract 36